Remibrutinib in Real-world Clinical Practice - a US Sub-study
NCT07358780
·
clinicaltrials.gov ↗
RECRUITING
Status
505
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Spontaneous Urticaria
Sponsor
Novartis Pharmaceuticals